Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Brunner

Showing results (41-50 of 564) with videos related to

Pageof 57
Sort By:
Lancet (London, England)|March 4, 2000
Angiotensin II receptor antagonistsM Burnier, H R Brunner
Contributions to Nephrology|January 1, 1976
Pathophysiological concepts of renovascular hypertensionH R Brunner, H Gavras
BMJ (Clinical Research Ed.)|December 1, 2001
Antihypertensive treatment and compliance. Study was too short and lacked active interventionM Burnier, H R Brunner
Schweizerische Medizinische Wochenschrift|September 25, 1982
[New therapeutic approaches to arterial hypertension]B Waeber, H R Brunner
Presse Medicale (Paris, France : 1983)|October 26, 1996
[Angiotensin II antagonists: a distinct therapeutic class]B Waeber, H R Brunner
The New England Journal of Medicine|September 23, 1976
Letter: Renin profiling in hypertensionH Gavras, H R Brunner
Expert Opinion on Investigational Drugs|May 1, 1997
Angiotensin II receptor antagonists - antihypertensive agentsM Burnier, H R Brunner
Schweizerische Medizinische Wochenschrift|August 17, 1996
[Ambulatory blood pressure monitoring in the assessment of the hypertensive patient]B Waeber, H R Brunner
Therapie|October 17, 1998
[Angiotensin II AT1 receptor antagonists: clinical development and future perspectives]M Burnier, H R Brunner
Schweizerische Medizinische Wochenschrift|October 5, 1974
[Renin and sodium in blood pressure regulation]H R Brunner, H Gavras
Pageof 57

Showing results (41-50 of 564) with videos related to

Sort By:
Pageof 57
Lancet (London, England)|March 4, 2000
Angiotensin II receptor antagonistsM Burnier, H R Brunner
Contributions to Nephrology|January 1, 1976
Pathophysiological concepts of renovascular hypertensionH R Brunner, H Gavras
BMJ (Clinical Research Ed.)|December 1, 2001
Antihypertensive treatment and compliance. Study was too short and lacked active interventionM Burnier, H R Brunner
Schweizerische Medizinische Wochenschrift|September 25, 1982
[New therapeutic approaches to arterial hypertension]B Waeber, H R Brunner
Presse Medicale (Paris, France : 1983)|October 26, 1996
[Angiotensin II antagonists: a distinct therapeutic class]B Waeber, H R Brunner
The New England Journal of Medicine|September 23, 1976
Letter: Renin profiling in hypertensionH Gavras, H R Brunner
Expert Opinion on Investigational Drugs|May 1, 1997
Angiotensin II receptor antagonists - antihypertensive agentsM Burnier, H R Brunner
Schweizerische Medizinische Wochenschrift|August 17, 1996
[Ambulatory blood pressure monitoring in the assessment of the hypertensive patient]B Waeber, H R Brunner
Therapie|October 17, 1998
[Angiotensin II AT1 receptor antagonists: clinical development and future perspectives]M Burnier, H R Brunner
Schweizerische Medizinische Wochenschrift|October 5, 1974
[Renin and sodium in blood pressure regulation]H R Brunner, H Gavras
Pageof 57